The Food and Drug Administration (FDA) yesterday said that another batch of AstraZeneca’s lipid-lowering drug Crestor was found to have been adulterated with counterfeit drugs, so the company has agreed to initiate a recall for all batches on the market.
The administration last weekend confirmed that batch number MV503 of Crestor 10mg film-coated tablets contained counterfeit drugs in similar packaging, and all the medication from that batch was recalled from hospitals and pharmacies.
“The agency received the report about the counterfeit drugs on Thursday last week and immediately launched an investigation; examinations confirmed that there were counterfeit drugs being sold,” administration Director-General Shou-Mei Wu (吳秀梅) said yesterday.
Photo: courtesy of the Taichung Health Bureau
The New Taipei District Prosecutors’ Office took two suspects into custody over the weekend, and they may face up to 10 years in prison or a fine up to NT$100 million (US$3.24 million) for producing counterfeit drugs under the Pharmaceutical Affairs Act (藥事法).
Another consignment of Crestor 10mg film-coated tablets, batch number MK479, was also found to contain counterfeit drugs, so the FDA said it asked AstraZeneca to recall all batches of the product in the interests of public safety.
“The main ingredient that has been added to the counterfeit drugs is actually another type of lipid-lowering drug, atorvastatin, that used to be commonly prescribed, so people who have taken the counterfeit drugs need not worry too much,” Wu said, adding that people should consult doctors or pharmacists if they have any questions.
According to National Health Insurance (NHI) Administration statistics, more than 200,000 boxes of Crestor are prescribed each month in Taiwan by NHI physicians, administration official Chih Lan-hui (遲蘭慧) said.
AstraZeneca told the administration that it has a sufficient quantity of the medication in stock to replace the recalled products, so patients would not be forced to take other types of drugs, she said.
Asked to respond to media reports that two other types of oral lipid-lowering drugs and one type of oral hypoglycemic drugs had been adulterated with counterfeit drugs and marketed under other brand names, the administration said it did not have any information on the issue, but that prosecutors and the administration would investigate.
The Mainland Affairs Council (MAC) yesterday said it is fully aware of the situation following reports that the son of ousted Chinese politician Bo Xilai (薄熙來) has arrived in Taiwan and is to marry a Taiwanese. Local media reported that Bo Guagua (薄瓜瓜), son of the former member of the Political Bureau of the Central Committee of the Communist Party of China, is to marry the granddaughter of Luodong Poh-Ai Hospital founder Hsu Wen-cheng (許文政). The pair met when studying abroad and arranged to get married this year, with the wedding breakfast to be held at The One holiday resort in Hsinchu
The Taipei Zoo on Saturday said it would pursue legal action against a man who was filmed climbing over a railing to tease and feed spotted hyenas in their enclosure earlier that day. In videos uploaded to social media on Saturday, a man can be seen climbing over a protective railing and approaching a ledge above the zoo’s spotted hyena enclosure, before dropping unidentified objects down to two of the animals. The Taipei Zoo in a statement said the man’s actions were “extremely inappropriate and even illegal.” In addition to monitoring the hyenas’ health, the zoo would collect evidence provided by the public
A decision to describe a Chinese Ministry of Foreign Affairs statement on Singapore’s Taiwan policy as “erroneous” was made because the city-state has its own “one China policy” and has not followed Beijing’s “one China principle,” Deputy Minister of Foreign Affairs Tien Chung-kwang (田中光) said yesterday. It has been a longstanding practice for the People’s Republic of China (PRC) to speak on other countries’ behalf concerning Taiwan, Tien said. The latest example was a statement issued by the PRC after a meeting between Singaporean Prime Minister Lawrence Wong (黃循財) and Chinese President Xi Jinping (習近平) on the sidelines of the APEC summit
‘SIGN OF DANGER’: Beijing has never directly named Taiwanese leaders before, so China is saying that its actions are aimed at the DPP, a foundation official said National Security Bureau (NSB) Director-General Tsai Ming-yen (蔡明彥) yesterday accused Beijing of spreading propaganda, saying that Chinese President Xi Jinping (習近平) had singled out President William Lai (賴清德) in his meeting with US President Joe Biden when talking about those whose “true nature” seek Taiwanese independence. The Biden-Xi meeting took place on the sidelines of the APEC summit in Peru on Saturday. “If the US cares about maintaining peace across the Taiwan Strait, it is crucial that it sees clearly the true nature of Lai and the ruling Democratic Progressive Party (DPP) in seeking Taiwanese independence, handles the Taiwan question with extra
RSS